Neoplasia/BPH

	A Cross-Sectional Study Assessing Association of Renal Cell Carcinoma Pathological Grade and Stage With Body Mass Index and Obesity Related Factors. Cancer Control Shrivastava S, Kauffman EC, Wightman P, Kwan ML, Tang L, Langston ME, Deng Z, Lee BR, Chipollini J, Batai K. PMID: 41746625 [PubMed - in process]
	A prescription-free, radiobiology-based framework for automated VMAT planning: A feasibility study in primary prostate cancer radiotherapy. Med Phys Kuhn D, Spohn SKB, Zamboglou C, Grosu AL, Baltas D, Sachpazidis I. PMID: 41746195 [PubMed - in process]
	Breathing-Zone Exposure to Aromatic Volatile Organic Compounds in Surgical Smoke During Transurethral Resection of Bladder Tumor: A Prospective Paired Monitoring Study. Toxics Jo SB, Ahn ST, Oh MM, Shim SH, Ahn CM, Oh SG, Kim JW. PMID: 41745804 [PubMed]
	Indoxyl Sulfate in the Gut-Kidney Axis: Pathophysiology and Clinical Significance in CKD-Associated Colorectal Cancer. Toxins (Basel) Shimizu H, Niwa T. PMID: 41745738 [PubMed - in process]
	MRI-Based Bladder Cancer Staging via YOLOv11 Segmentation and Deep Learning Classification. Diseases Katongtung P, Shiangjen K, Cholamjiak W, Naravejsakul K. PMID: 41745083 [PubMed]
	Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity-A Case Report. Curr Oncol Lewetag RD, Kluthe K, Trautwein NF, Lauer UM, la Fougère C, Sipos B, Zender L, Hinterleitner C, Singer S, Hinterleitner M. PMID: 41744869 [PubMed - in process]
	Historical Perspective of HER2 Testing and Treatment in Prostate Cancer. Curr Oncol Zamalloa N, Rose J, Lap CJ, Rajendran R, Estephan F, Jatwani K, Poudel A, Subrahmanyam R, Hurley PJ, Nava VE, Jain M. PMID: 41744855 [PubMed - in process]
	The Gut-Prostate Axis: Decoding the Interplay of Environmental Factors, Microbial Metabolites, and Hormonal Regulation in Prostate Cancer Pathogenesis. Technol Cancer Res Treat Sandeep G, Pahari S, Nayak V, Gundamaraju R, Mishra P, Misra A. PMID: 41744425 [PubMed - in process]
	Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4. J Clin Oncol Armstrong AJ, Morris MJ, Abida W, Aggarwal RR, Antonarakis ES, Attard G, Beltran H, Bryce A, Carducci MA, Cheng HH, Chen DL, Chi KN, Childs DS, Dahut W, Emmett L, Fizazi K, Gafita A, George DJ, Hermann K, Hofman MS, Hope T, Hussain M, Kelly WK, Kessler E, Kuo PH, Lang J, Liu G, Marshall CH, Morgans AK, McKay RR, Nanus D, Nelson P, Paller C, Reichert ZR, Ryan CJ, Sartor AO, Schöder H, Schwartz LH, Sharifi N, Stadler WM, Stein M, Sternberg CN, Szmulewitz RZ, Tagawa ST, Sokolova AO, Wyatt AW, Yamoah K, Yu EY, Halabi S, Scher HI, PCWG4 Writing Group. PMID: 41744290 [PubMed - as supplied by publisher]
	Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026). J Urol Lin DW, Carlsson S, Filson CP, Kim SK, Kirkby E, Konety BR, Purysko AS, Souter LH. PMID: 41744286 [PubMed - as supplied by publisher]
	The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical care. BJU Int Sharma A, Campbell T, Kanabar S, Soanes H, Sathanapally G, Bates A, John R, Adams C, Brassill A, Lennon B, Sinha S, Flaxman L, von Hasseln V, Camilleri P, Sabharwal A, Charlton P, Andrade G, Tuthill M, Protheroe A, Lamb AD, Leslie T, Leiblich A, Lopez F, Verrill C, Gleeson F, MacPherson R, Hamdy FC, Bell R, Bryant RJ. PMID: 41744174 [PubMed - as supplied by publisher]
	Preoperative gamma-glutamyl transferase to lymphocyte ratio predicts recurrence in non-muscle-invasive bladder cancer. Front Oncol Zhang X, Su S, Liu L, Song F, Cui X, Cao Y, Li C, Li S, He H, Kang Y, Zhang J. PMID: 41743958 [PubMed]
	Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis. Front Oncol Cui F, Zhang Y, Liu Z, Zhou Y, Man C, Fan Y. PMID: 41743950 [PubMed]
	Causal relationships between plasma metabolites and prostate cancer: A Mendelian randomization study exploring immune and inflammatory mediators. Curr Urol Huang M, Ning D, Tong T, Teng Q, Cao F, Guan Y, Wang Y, Lei H, Pang J. PMID: 41743923 [PubMed]
	Analysis of overall survival in patients with second primary malignancies following with the first diagnosis of nonmetastatic prostate cancer: A study utilizing the Surveillance, Epidemiology, and End Results database. Curr Urol Zhu G, Wang R, Xiong T, Liu Z, Lin Z, Niu Y. PMID: 41743915 [PubMed]
	A Rare Case of TFE3-Rearranged and SMARCB1-Mutated Renal Cell Carcinoma: Diagnostic and Therapeutic Complexities. Case Rep Oncol Med Pecorin PJ, Dhliwayo N, Christ T, Westbrook T. PMID: 41743914 [PubMed]
	Bibliometric Insights into Aging and Immune Function in Prostate Cancer: Focus on Chronic Inflammation. J Inflamm Res Lai S, Lin C, Li L, Qiu W, Zhang J, Guo T. PMID: 41743662 [PubMed]
	Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer. Research (Wash D C) Ye J, Xie Y, Wang J, Wu R, Li D, Yoo KH, Wusiman D, Cho WC, Lyu Z, Feng D. PMID: 41743623 [PubMed]
	Enhanced recovery after radical cystectomy for bladder cancer: a prospective observational case -control study. BMC Urol Habicher M, Swoboda C, Hauptmann A, Koch C, Diemer T, Paul AC, Markmann M, Schneck E, Wagenlehner F, Wolff M, Sander M. PMID: 41742085 [PubMed - as supplied by publisher]
	The development of a model of acculturation and health practices among sub-Saharan African Men (MAPS) in the United States: a grounded theory study of prostate cancer early detection. BMC Public Health Kaninjing E, Ogunsanya M, Asiedu G, Francis D, Van Voorhis K, Heppner W, Dickey SL, Taylor A, Mijena J, Dagne G, Young ME, Gwede C, Odedina F. PMID: 41742067 [PubMed - as supplied by publisher]

Articles 1 - 20 / 185819

Page 1 of 9291



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy